SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-009633
Filing Date
2019-05-28
Accepted
2019-05-28 13:19:04
Documents
81
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0319_americanbrivision.htm 10-Q 637618
2 CERTIFICATION f10q0319ex31-1_americanbri.htm EX-31.1 13681
3 CERTIFICATION f10q0319ex31-2_americanbri.htm EX-31.2 13985
4 CERTIFICATION f10q0319ex32-1_americanbri.htm EX-32.1 5652
5 CERTIFICATION f10q0319ex32-2_americanbri.htm EX-32.2 5854
  Complete submission text file 0001213900-19-009633.txt   4730797

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE abvcd-20190331.xml EX-101.INS 803246
7 XBRL SCHEMA FILE abvcd-20190331.xsd EX-101.SCH 60827
8 XBRL CALCULATION FILE abvcd-20190331_cal.xml EX-101.CAL 66863
9 XBRL DEFINITION FILE abvcd-20190331_def.xml EX-101.DEF 214352
10 XBRL LABEL FILE abvcd-20190331_lab.xml EX-101.LAB 370273
11 XBRL PRESENTATION FILE abvcd-20190331_pre.xml EX-101.PRE 327314
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 845-551-8728
American BriVision (Holding) Corp (Filer) CIK: 0001173313 (see all company filings)

IRS No.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-91436 | Film No.: 19856860
SIC: 2834 Pharmaceutical Preparations